Four manuscripts on rehabilitation in multiple sclerosis published

Multiple sclerosis counts as one of the most frequent autoimmune mediated, chronic progressive neurological diseases that can, already in young adulthood, cause severe neurological symptoms. In close cooperation of the Chair of Human Movement Science and the Center for clinical Neuroplasticity, Medical Park Loipl, a total of four manuscripts were recently published.

 

They covered the effects of inpatient neurorehabilitation on the sensorimotor performance, especially gait, and statistical models to predict rehabilitation success. Further, the association of different psychometric measures and sensorimotor performance with the quality of life was examined, in order to better estimate the effects of rehabilitation on the well-being of persons with multiple sclerosis.

In total, four manuscripts were published: Two in Multiple Sclerosis and Related Disorders, and each one in Journal of Clinical Medicine and in Multiple Sclerosis International.

Gulde P, Hermsdörfer J, & Rieckmann P (2021). Introduction of the Watzmann Severity Scale: A sensorimotor approach to estimate the course of inpatient rehabilitation in multiple sclerosis. Multiple Sclerosis and Related Disorders, 48(6): 102674. DOI: 10.1016/j.msard.2020.102674 https://www.msard-journal.com/article/S2211-0348(20)30748-3/fulltext

Gulde P, Hermsdörfer J, & Rieckmann P (2021). Inpatient rehabilitation: Prediction of changes in sensorimotor performance in multiple sclerosis: A pilot study. Journal of Clinical Medicine, 10(10): 2177. DOI: 10.3390/jcm10102177 https://www.mdpi.com/2077-0383/10/10/2177

Gulde P, Hermsdörfer J, & Rieckmann P (2021). Speed, but not smoothness of gait, reacts to rehabilitation in multiple sclerosis. Multiple Sclerosis International, 12: 1-8. DOI: 10.1155/2021/5589562 https://www.hindawi.com/journals/msi/2021/5589562/

Gulde P, Hermsdörfer J, & Rieckmann P (2021). Sensorimotor performance does not predict quality of life in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders, 52(3): 102986. DOI: 10.1016/j.msard.2021.102986 https://www.msard-journal.com/article/S2211-0348(21)00253-4/fulltext